…the private sector is hoping to capitalize on the ongoing medicalization of psychedelics through manufacturing, drug development, and clinical administration of these substances and their proprietary, patentable derivatives. It isn’t news that there are certain for-profit companies that have been openly challenged on their questionable practices in this process of monetization. When examined closely… U.S. patent laws…
Compared to other psychotropic drugs available in the 1950s, LSD induced “something phenomenal, … of unimaginable intensity,” according to its creator Albert Hofmann. Speaking in an interview in 2004, he continued, “There is a vast difference between the emotional experience of this sensation and its purely abstract, philosophical description. It would be like trying to…
Experts say women, low-income people and people in rural areas are disproportionately affected by the prescribing crackdown. The same goes for people of color and Black people especially, who are more likely have their pain dismissed by doctors or be profiled as a drug addict or dealer due to stigma and racism. “We can confirm that law enforcement, the…
Experts say women, low-income people and people in rural areas are disproportionately affected by the prescribing crackdown. The same goes for people of color and Black people especially, who are more likely have their pain dismissed by doctors or be profiled as a drug addict or dealer due to stigma and racism. “We can confirm that law enforcement, the…
The Department of Justice is fighting to strip the billionaire Sackler family of the sweeping legal immunity granted as part of a controversial $4.5 billion opioid settlement. …in filings, DOJ trustee Harrington argued that the releases are unconstitutional because they deprive people of the ability to make legal claims – a form of property – against the…
Oregon Attorney General Ellen Rosenblum said she was weighing an appeal… the questioning of Sackler in the 337-page deposition centered on Purdue’s marketing of OxyContin. Following the release of the revealing deposition’s contents – which Purdue fought for three years to keep secret… the settlement denies the thousands of plaintiffs – whose lawsuits total a staggering $40 trillion – their…
The United States Drug Enforcement Administration (“DEA”) has proposed an increase in the manufacture… psilocin and psilocybin for clinical trial and research purposes… stated that its objective was to assist in the development of new federally approved therapies. …increased its production goals for psilocin and psilocybin, which are the main psychoactive components of magic mushrooms. Initially, the…
More than two-thirds of Congress cashed a pharma campaign check in 2020… the ruling, which is exactly what the Sacklers demanded, grants releases from liability for harm caused by the company’s aggressive and sometimes illegal marketing of the discontinued opioid OxyContin and other opioids. In addition to the Sacklers themselves, hundreds of individuals and organizations…
…[is mandated] to develop a long-term strategic plan that ensures safety, accessibility, and affordability on psilocybin services. Measure 109 requires the Board to create a system for psilocybin services that is safe, equitable, and accessible… Original Article (Truffle Report):Oregon psilocybin board partners with harvard’s poplarArtwork Fair Use: Another Believer
The right to use psychedelic[s] is currently navigating through the legislature, with places like Oregon, Washington DC, [et al.] decriminalizing psychedelic plant-based drugs… A revolution is sweeping mental health. Not since President Nixon declared war on drugs have researchers and traditional practitioners been able to share the results. The early data shows that plant-based therapy…
Recent Comments